Outsourcing (or contracting out) is often defined as the delegation of non-core operations or jobs from internal production within a business to an external entity (such as a subcontractor) that specializes in that operation. Outsourcing is a business decision that is often made to lower costs or focus on competencies. A related term, off shoring, means transferring work to another country, typically overseas. Off shoring is similar to outsourcing when companies hire overseas subcontractors, but differs when companies transfer work to the same company in another country. "Outsourcing" became a popular buzzword in business and management in the mid-1990s.

Overview

---

Outsourcing is defined as the "the process of transferring an existing business function, including the relevant physical and/or human assets, to an external provider in order to strategically use outside resources to perform activities previously handled in-house" (Baziotopoulos, 2006).

More on [ Outsourcing ]

Farmavita.Net - Pharmaceutical Licensing Network

Medicines required
Thu, 17 Dec 2009 07:33:58 +0100
Intermediary Pharma Group from Azerbaijan, is interested in obtaining the following finished pharmaceutical products for permanent partnership with full dossiers for registration: Ceftriaxon 1g, 0.5g with ligocaine; Ampicilline +Sulbactam 1.5g with solvent; Cefotaxime 1g, 0.5g,with lidocaine; Amikacine.
Victory Pharmaceuticals - Late Stage Development Program in Pain Management
Tue, 15 Dec 2009 23:21:58 +0100
Development-stage pain products The Company seeks to divest its development-stage pain products MGX-001 (extended release morphine combined with an atypical stimulant) and MGX-002 (a follow-on opioid combined with an atypical stimulant). These products are expected to significantly reduce commonly-experienced side effects versus existing opiate therapies.
Fermentation Technologies
Fri, 11 Dec 2009 13:12:33 +0100
Farmavita.Net member is seeking bacteria strains and fermentation technologies to produce the following products Lycopene, Chlortetracycline and Acetylisovaleryltylosin.
Orphan & Ultra-Orphan Drugs
Thu, 19 Nov 2009 16:29:12 +0100
Commercialisation Market Access Strategies for Orphan Ultra-Orphan Drugs January 13-14, 2010, Brussels, Belgium Focusing on orphan ultra orphan drugs, this event will provide a fresh and original perspective on one of the most fascinating fields in market patient access. Communicating value and cost-effectiveness with payers, regulators and other key stakeholders, in such niche markets, requires innovation out-of-the box models and strategies.
Co- development offer for innovatve topical for Psoriasis
Thu, 29 Oct 2009 16:00:29 +0100
Innovatve topical for Psoriasis We are interested in Co- development of an innovative topical formulation presented in a delivery system particularly targeted for treatment of Psoriasis and other dermatoses of hyperkeratotic nature. The formulation comprises of ingredients having anti inflammatory and a keratosolvent properties. The innovative formulation presented in a specially designed delivery system is patent potential and has superior clinical efficacy as compared to topical keratolytics such as Salicylic Acid, coal tar and synthetic retinoids.
Pharma To Market
Wed, 14 Oct 2009 13:23:16 +0100
Pharma To Market provides global regulatory support services and outsourcing solutions to the pharmaceutical industry. Based in Australia, we are unique in that we offer regulatory and technical support for submissions in key global markets including Australia, New Zealand, USA, Europe, Canada, and South East Asia. Pharma To Market are licensed vendors of the Regulatory Solutions Suite (RSS) of software from ISI. We offer full implementation and maintenance services to companies in Australia and New Zealand for ISI's Regulatory Solutions Suite including eCTDXPress, ISIWriter, ISIToolBox and ISIPublisher. Pharma To Market also offer complete outsourcing solutions for eCTD and paper publishing.

Subscribe to Outsourcing RSS feed